Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 13:37:100832.
doi: 10.1016/j.lana.2024.100832. eCollection 2024 Sep.

Clinical features of Chagas disease progression and severity

Maria Carmo P Nunes  1 , Caryn Bern  2 , Eva H Clark  3 , Antonio L Teixeira  4   5 , Israel Molina  6
Affiliations
Review

Clinical features of Chagas disease progression and severity

Maria Carmo P Nunes et al. Lancet Reg Health Am. .

Abstract

Chagas disease, the most common form of nonischaemic cardiomyopathy globally, is one of the leading causes of morbidity and mortality in Latin America. Chagas cardiomyopathy has a wide clinical spectrum and prognosis, which is primarily determined by the severity of left ventricular dysfunction. Chagas disease also affects the brain, particularly manifesting as cardioembolic strokes and cognitive impairments. Disease progression is influenced by various factors such as anti-parasite treatments, host-parasite interactions, and other determinants. This review explores Chagas disease, covering clinical presentations, the range of severity of Chagas cardiomyopathy, and neurological manifestations. We investigate factors that influence the progression of cardiomyopathy, including anti-parasitic treatments, interactions between hosts and parasites, and the influence of social determinants on the course of the disease. This review analyses key prognostic factors associated with the progression and mortality of Chagas cardiomyopathy, offering insights into this potentially fatal illness.

Keywords: Chagas cardiomyopathy; Chagas disease; Progression; Severity.

PubMed Disclaimer

Conflict of interest statement

C.B. has received royalties for Chagas disease topics from UpToDate (Wolters Kluwer Health). M.C.P.N., E.H.P., A.L.T., and I.M. have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Clinical features, electrocardiogram (ECG), and echocardiographic findings based on the stage of Chagas disease.
See this image and copyright information in PMC

References

    1. Moolani Y., Bukhman G., Hotez P.J. Neglected tropical diseases as hidden causes of cardiovascular disease. PLoS Negl Trop Dis. 2012;6(6) - PMC - PubMed
    1. Bern C. Chagas' disease. N Engl J Med. 2015;373(5):456–466. - PubMed
    1. Nunes M.C., Dones W., Morillo C.A., Encina J.J., Ribeiro A.L., Council on Chagas Disease of the Interamerican Society of C Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62(9):767–776. - PubMed
    1. Organization WH . World Health Organization website; 2018. Chagas disease (American trypanosomiasis)http://www.who.int/mediacentre/factsheets/fs340/en.2019 - PMC - PubMed
    1. Carrasco H.J., Segovia M., Llewellyn M.S., et al. Geographical distribution of Trypanosoma cruzi genotypes in Venezuela. PLoS Negl Trop Dis. 2012;6(6) - PMC - PubMed

LinkOut - more resources